Clinical Trial of COVID-19 THURSDAY, June 11, 2020 — A large clinical trial of the first U.S. COVID-19 vaccine could begin next month, according to Moderna Inc., which developed the vaccine with the U.S. National...
Leishmaniasis The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection. There are currently...
Het Catharina Ziekenhuis is een onderzoek gestart naar een nieuwe behandeling voor patiënten met uitgezaaide darmkanker in het buikvlies. Deze patiënten, die palliatief worden behandeld, krijgen naast hun reguliere...
Janssen has announced that the FDA has expanded the label of its androgen receptor inhibitor Erleada (apalutamide) to include the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC). The...
Sovateltide Pharmazz, Inc, a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, announced the initiation of dosing in its pivotal, phase...
How to Send Better Email: 7 Ways To Level Up Your Email Skills Today What’s in this post: The best tools for email What to say instead of “Let me know if you have any questions” and “Please let me know” An email...
AstraZeneca, a global, science-led biopharmaceutical company, announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed...
Teva Pharmaceutical Industries Ltd announced positive topline results from the phase IIIb FOCUS study that evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who...
Je kunt vandaag niet over marketing praten zonder dat het gesprek leidt naar artificial intelligence (AI) of machine learning (ML). Ooit aangeprezen als wondermiddelen voor gegevensverzameling, analyse en...
We gebruiken cookies om ervoor te zorgen dat onze website zo soepel mogelijk draait. Als u doorgaat met het gebruiken van de website, gaan we er vanuit dat u ermee instemt.